Tech Company Financing Transactions

Eradivir Funding Round

Eradivir, based in West Lafayette, secured $10.3 million from private investors.

Transaction Overview

Company Name
Announced On
9/26/2024
Transaction Type
Venture Equity
Amount
$10,250,000
Round
Series A
Investors

private investors (Philip Low)

Proceeds Purpose
The company intends to use the funds to conduct a Phase 2a challenge study of its EV25 influenza treatment.

Company Information

Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
1281 Win Hentschel Boulevard
West Lafayette, IN 47906
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
Eradivir's founder, Dr. Philip S. Low, has successfully developed multiple FDA-approved targeted small molecules. These therapies all function by attaching various payloads to ligands, which bind with high specificity to diseased cells. Examples of approved molecules include a radiotherapy drug for prostate cancer and an intraoperative imaging agent for lung and ovarian cancers. Several others are currently in clinical trials (e.g., treatments for cancer, malaria, and sickle cell anemia). Eradivir was founded in March 2020 to advance a promising application of this platform in combating multiple disease states, initially focusing on influenza and other respiratory infections.
Profile
Eradivir LinkedIn Company Profile
Social Media
Eradivir Company Twitter Account
Company News
Eradivir News
Facebook
Eradivir on Facebook
YouTube
Eradivir on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Martin Low
  Martin Low LinkedIn Profile  Martin Low Twitter Account  Martin Low News  Martin Low on Facebook
Chief Operating Officer
Stewart Low
  Stewart Low LinkedIn Profile  Stewart Low Twitter Account  Stewart Low News  Stewart Low on Facebook
Chief Scientific Officer
Philip Low
  Philip Low LinkedIn Profile  Philip Low Twitter Account  Philip Low News  Philip Low on Facebook
Vice President
Madduri Srinivasarao
  Madduri Srinivasarao LinkedIn Profile  Madduri Srinivasarao Twitter Account  Madduri Srinivasarao News  Madduri Srinivasarao on Facebook
VP - R & D
Ananda Kanduluru
  Ananda Kanduluru LinkedIn Profile  Ananda Kanduluru Twitter Account  Ananda Kanduluru News  Ananda Kanduluru on Facebook
VP - R & D
Jeffery Nielsen
  Jeffery Nielsen LinkedIn Profile  Jeffery Nielsen Twitter Account  Jeffery Nielsen News  Jeffery Nielsen on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/26/2024: K1x venture capital transaction
Next: 9/26/2024: Cyvatar venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary